Menu
Sign In Search Podcasts Charts Entities Add Podcast API Pricing
Podcast Image

Clean Slate

Deadly Runners on navigating relationships in recovery

21 Jun 2024

Description

Content warning: Drinking alcohol; addiction; and suicide. Deadly Runners founder Georgia Weir first tried running in 2012 to help her cope and manage her battle with mental health and addiction, and it worked. In 2013, she ran the New York marathon after six months of training. This was a life-changing experience for Georgia. In this episode, we’ll hear from Georgia about her recovery journey, and also from her husband Michael Weir about his experience as her partner through her recovery, as well as more about the Deadly Runners grassroots movement. You’ll also hear from Dr Chris Davis, Co-Founder & Chief Medical Officer at Clean Slate Clinic, for his clinical insights. Clean Slate is an eight part podcast series that unpacks Australia’s complicated relationship with alcohol from multiple angles; bringing you both lived experience stories and clinical insights. This podcast is brought to you by Clean Slate Clinic; a healthtech social enterprise focused on helping Australians keen to detox from alcohol, safely from home. Hosted by Pia Clinton-Tarestad, Co-founder & CEO of Clean Slate Clinic. To find out more about Clean Slate Clinic: ⁠Website⁠ ⁠Instagram⁠ ⁠Linkedin⁠ To find out more about Deadly Runners: ⁠Website⁠ ⁠Instagram⁠ Clean Slate Clinic is a regulated health service, but the Clean Slate podcast is an educational resource and not a substitute for professional health advice, treatment or assessment. If you are struggling with any of the issues raised in this podcast, please see a healthcare professional or call Lifeline on 13 11 14.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

No transcription available yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.